1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2023Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data TRANSLATIONAL LUNG CANCER RESEARCH
2023Real-World Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in the Era of Current-Generation Devices JOURNAL OF CLINICAL MEDICINE
2023Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors TRANSLATIONAL LUNG CANCER RESEARCH
2023Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia JOURNAL OF CLINICAL HYPERTENSION
2023Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma JOURNAL OF CLINICAL ONCOLOGY
2023Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus PLOS ONE
2023Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE studyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2023Preface CLINICAL AND MOLECULAR HEPATOLOGY
2023Predicting outcomes of continuous renal replacement therapy using body composition monitoring: a deep-learning approach SCIENTIFIC REPORTS
2023Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study PLOS ONE
2023Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer FUTURE ONCOLOGY
2023Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers HEPATOLOGY
2023Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and OutcomesJACC-CARDIOVASCULAR INTERVENTIONS
2024Pentraxin 3 as an Immune Recovery Marker in HIV Infection After Combination Antiretroviral TherapyAIDS RESEARCH AND HUMAN RETROVIRUSES
2024Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial EUROPEAN UROLOGY
2023Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJAMA NETWORK OPEN
2023Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study JOURNAL OF HEPATOLOGY
2023Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTON CANCER DISCOVERY
2023Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical TrialCIRCULATION
2023Olfactory marker protein regulates adipogenesis via the cAMP-IκBα pathway MOLECULAR AND CELLULAR ENDOCRINOLOGY

Recent Submissions

Browse

Links